ANTX AN2 Therapeutics, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $171.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $32.3M | $0 |
| 2022-Q2 | $650.0K | $0 |
| 2022-Q3 | $195.0K | $0 |
| 2022-Q4 | $0 | $1.5M |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $53.8K | $0 |
| 2023-Q3 | $16.0M | $3.8M |
| 2023-Q4 | $0 | $240.8K |
| 2024-Q1 | $0 | $6.2M |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $1.6M | $3.8M |
| 2024-Q4 | $423.1K | $0 |
| 2025-Q1 | $0 | $23.6K |
| 2025-Q2 | $20.9K | $3.1M |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $4.1K |
| 2026-Q1 | $0 | $49.9K |
| 2026-Q2 | $0 | $1.2K |
| 2026-Q3 | $11.6K | $343.0K |
| 2026-Q4 | $0 | $11.9K |
Bought$51.2M28 buy days
Sold$19.1M68 sell days
Net insider flow+$32.2Mnet buying · 5 years
Latest trade2026-11-05Eizen Joshua M
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-11-05 | Sell | Eizen Joshua M | Other officer | 2,826 | $4.22 | $11.9K | 1 |
| 2026-09-09 | Sell | Readnour Robin Shane | Director | 1,108 | $6.02 | $6.7K | 2 |
| 2026-09-08 | Sell | Readnour Robin Shane | Director | 10,019 | $6.02 | $60.3K | 2 |
| 2026-09-03 | Sell | Readnour Robin Shane | Director | 6,100 | $6.07 | $37.0K | 2 |
| 2026-09-01 | Buy | FitzPatrick Margaret M | Director | 2,098 | $5.53 | $11.6K | 1 |
| 2026-09-01 | Sell | Williams Sarah Joanne | Other officer | 272 | $5.53 | $1.5K | 1 |
| 2026-08-17 | Sell | Readnour Robin Shane | Director | 35,402 | $6.01 | $212.7K | 2 |
| 2026-07-08 | Sell | Eizen Joshua M | Other officer | 5,945 | $4.17 | $24.8K | 1 |
| 2026-05-29 | Sell | Williams Sarah Joanne | Other officer | 265 | $4.43 | $1.2K | 1 |
| 2026-03-03 | Sell | Williams Sarah Joanne | Other officer | 327 | $1.06 | $347 | 1 |
| 2026-01-06 | Sell | Eizen Joshua M | Other officer | 6,931 | $1.01 | $7.0K | 1 |
| 2026-01-06 | Sell | Chanda Sanjay | Other C-suite | 5,956 | $1.01 | $6.0K | 1 |
| 2026-01-06 | Sell | Day Lucy | CFO | 5,512 | $1.01 | $5.6K | 1 |
| 2026-01-06 | Sell | Prior Stephen David | Other C-suite | 2,858 | $1.01 | $2.9K | 1 |
| 2026-01-05 | Sell | Eizen Joshua M | Other officer | 17,923 | $1.00 | $17.9K | 1 |
| 2026-01-05 | Sell | Prior Stephen David | Other C-suite | 3,604 | $1.00 | $3.6K | 1 |
| 2026-01-05 | Sell | Chanda Sanjay | Other C-suite | 3,295 | $1.00 | $3.3K | 1 |
| 2026-01-05 | Sell | Day Lucy | CFO | 3,295 | $1.00 | $3.3K | 1 |
| 2025-11-04 | Sell | Eizen Joshua M | Other officer | 2,819 | $1.14 | $3.2K | 1 |
| 2025-11-04 | Sell | Prior Stephen David | Other C-suite | 765 | $1.14 | $872 | 1 |
| 2025-06-02 | Buy | Easom Eric | CEO | 10,000 | $1.07 | $10.7K | 1 |
| 2025-05-30 | Sell | Leonard Braden Michael | 10% owner | 432,000 | $1.01 | $436.5K | 2 |
| 2025-05-28 | Sell | Leonard Braden Michael | 10% owner | 2,300,000 | $1.15 | $2.7M | 3 |
| 2025-05-28 | Buy | FitzPatrick Margaret M | Director | 8,610 | $1.18 | $10.2K | 1 |
| 2025-01-03 | Sell | Eizen Joshua M | Other officer | 9,663 | $1.34 | $12.9K | 1 |
| 2025-01-03 | Sell | Day Lucy | CFO | 2,957 | $1.34 | $4.0K | 1 |
| 2025-01-03 | Sell | Chanda Sanjay | Other C-suite | 2,957 | $1.34 | $4.0K | 1 |
| 2025-01-03 | Sell | Prior Stephen David | Other C-suite | 2,029 | $1.34 | $2.7K | 1 |
| 2024-12-10 | Buy | Readnour Robin Shane | Director | 5,000 | $1.49 | $7.4K | 1 |
| 2024-12-09 | Buy | Readnour Robin Shane | Director | 30,772 | $1.43 | $44.0K | 2 |
| 2024-12-06 | Buy | Readnour Robin Shane | Director | 19,228 | $1.45 | $27.9K | 2 |
| 2024-11-27 | Buy | Readnour Robin Shane | Director | 25,000 | $1.42 | $35.5K | 1 |
| 2024-11-27 | Buy | Zakrzewski Joseph S | Director | 2,000 | $1.40 | $2.8K | 1 |
| 2024-11-26 | Buy | Readnour Robin Shane | Director | 12,500 | $1.39 | $17.4K | 1 |
| 2024-11-20 | Buy | Readnour Robin Shane | Director | 50,000 | $1.15 | $57.7K | 2 |
| 2024-11-19 | Buy | Readnour Robin Shane | Director | 150,000 | $1.03 | $155.2K | 2 |
| 2024-11-19 | Buy | Zakrzewski Joseph S | Director | 5,000 | $1.01 | $5.0K | 1 |
| 2024-11-18 | Buy | Easom Eric | CEO | 50,000 | $1.00 | $50.0K | 1 |
| 2024-11-18 | Buy | Zakrzewski Joseph S | Director | 20,000 | $1.00 | $20.0K | 1 |
| 2024-08-14 | Buy | Leonard Braden Michael | 10% owner | 1,500,000 | $1.04 | $1.6M | 1 |
| 2024-08-09 | Sell | RA Capital Healthcare Fund LP | 10% owner | 3,525,094 | $1.08 | $3.8M | 2 |
| 2024-01-18 | Sell | Zakrzewski Joseph S | Director | 100,000 | $19.11 | $1.9M | 1 |
| 2024-01-16 | Sell | Aziz Kabeer | Director | 100,000 | $19.65 | $2.0M | 2 |
| 2024-01-16 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 100,000 | $19.65 | $2.0M | 2 |
| 2024-01-12 | Sell | Readnour Robin Shane | Director | 1,425 | $21.91 | $31.2K | 2 |
| 2024-01-10 | Sell | Readnour Robin Shane | Director | 3,669 | $21.93 | $80.4K | 2 |
| 2024-01-09 | Sell | Krause Kevin Michael | Other C-suite | 7,417 | $20.14 | $149.4K | 1 |
| 2024-01-02 | Sell | Easom Eric | CEO | 2,777 | $20.09 | $55.8K | 1 |
| 2024-01-02 | Sell | Krause Kevin Michael | Other C-suite | 2,583 | $20.12 | $52.0K | 1 |
| 2023-11-14 | Sell | Aziz Kabeer | Director | 1,810 | $16.15 | $29.2K | 2 |
| 2023-11-14 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 1,810 | $16.15 | $29.2K | 2 |
| 2023-10-02 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 5,672 | $16.07 | $91.1K | 2 |
| 2023-10-02 | Sell | Aziz Kabeer | Director | 5,672 | $16.07 | $91.1K | 2 |
| 2023-09-29 | Sell | Aziz Kabeer | Director | 99,101 | $16.28 | $1.6M | 2 |
| 2023-09-29 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 99,101 | $16.28 | $1.6M | 2 |
| 2023-09-28 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 8,516 | $16.11 | $137.2K | 2 |
| 2023-09-28 | Sell | Aziz Kabeer | Director | 8,516 | $16.11 | $137.2K | 2 |
| 2023-09-27 | Sell | Aziz Kabeer | Director | 841 | $16.07 | $13.5K | 2 |
| 2023-09-27 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 841 | $16.07 | $13.5K | 2 |
| 2023-09-13 | Sell | Aziz Kabeer | Director | 400 | $16.00 | $6.4K | 2 |
| 2023-09-13 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 400 | $16.00 | $6.4K | 2 |
| 2023-09-07 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 3,378 | $16.05 | $54.2K | 2 |
| 2023-09-07 | Sell | Aziz Kabeer | Director | 3,378 | $16.05 | $54.2K | 2 |
| 2023-09-06 | Sell | Aziz Kabeer | Director | 3,762 | $16.02 | $60.3K | 2 |
| 2023-09-06 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 3,762 | $16.02 | $60.3K | 2 |
| 2023-08-23 | Sell | Aziz Kabeer | Director | 400 | $16.00 | $6.4K | 2 |
| 2023-08-23 | Sell | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 400 | $16.00 | $6.4K | 2 |
| 2023-08-18 | Buy | RA Capital Healthcare Fund LP | 10% owner | 1,777,778 | $9.00 | $16.0M | 1 |
| 2023-05-15 | Buy | Easom Eric | CEO | 10,000 | $5.38 | $53.8K | 1 |
| 2022-11-14 | Sell | Easom Eric | CEO | 23 | $15.04 | $346 | 1 |
| 2022-11-10 | Sell | Easom Eric | CEO | 4,413 | $15.32 | $67.6K | 1 |
| 2022-11-09 | Sell | Easom Eric | CEO | 10,111 | $15.61 | $157.8K | 1 |
| 2022-11-08 | Sell | Easom Eric | CEO | 7,055 | $15.58 | $109.9K | 2 |
| 2022-11-07 | Sell | Easom Eric | CEO | 12,203 | $16.04 | $195.7K | 2 |
| 2022-11-04 | Sell | Easom Eric | CEO | 8,828 | $15.80 | $139.5K | 1 |
| 2022-11-03 | Sell | Easom Eric | CEO | 14,165 | $15.75 | $223.0K | 2 |
| 2022-11-02 | Sell | Easom Eric | CEO | 1,544 | $15.07 | $23.3K | 1 |
| 2022-10-31 | Sell | Easom Eric | CEO | 2,688 | $15.39 | $41.4K | 1 |
| 2022-10-28 | Sell | Easom Eric | CEO | 1,683 | $15.09 | $25.4K | 1 |
| 2022-10-27 | Sell | Easom Eric | CEO | 924 | $15.36 | $14.2K | 1 |
| 2022-10-26 | Sell | Easom Eric | CEO | 1,678 | $15.10 | $25.3K | 1 |
| 2022-10-25 | Sell | Easom Eric | CEO | 4,806 | $15.75 | $75.7K | 2 |
| 2022-10-24 | Sell | Easom Eric | CEO | 2,866 | $16.17 | $46.3K | 1 |
| 2022-10-21 | Sell | Easom Eric | CEO | 13,951 | $16.36 | $228.2K | 2 |
| 2022-10-20 | Sell | Easom Eric | CEO | 7,293 | $16.68 | $121.7K | 2 |
| 2022-08-04 | Buy | RA Capital Healthcare Fund LP | 10% owner | 100 | $7.99 | $799 | 1 |
| 2022-08-03 | Buy | RA Capital Healthcare Fund LP | 10% owner | 1,809 | $7.48 | $13.5K | 1 |
| 2022-07-27 | Buy | RA Capital Healthcare Fund LP | 10% owner | 8,281 | $7.91 | $65.5K | 1 |
| 2022-07-26 | Buy | RA Capital Healthcare Fund LP | 10% owner | 14,938 | $7.71 | $115.2K | 1 |
| 2022-06-21 | Buy | RA Capital Healthcare Fund LP | 10% owner | 302 | $7.99 | $2.4K | 1 |
| 2022-06-14 | Buy | RA Capital Healthcare Fund LP | 10% owner | 61,424 | $7.97 | $489.5K | 1 |
| 2022-06-13 | Buy | RA Capital Healthcare Fund LP | 10% owner | 20,000 | $7.90 | $158.0K | 1 |
| 2022-03-29 | Buy | RA Capital Healthcare Fund LP | 10% owner | 1,666,666 | $15.00 | $25.0M | 2 |
| 2022-03-29 | Buy | Aziz Kabeer | Director | 166,666 | $15.00 | $2.5M | 1 |
| 2022-03-29 | Buy | Adjuvant Global Health Technology Fund, L.P. | 10% owner | 166,666 | $15.00 | $2.5M | 1 |
| 2022-03-29 | Buy | Readnour Robin Shane | Director | 153,334 | $15.00 | $2.3M | 2 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| RA Capital Healthcare Fund LP | 10% owner | $41.8M | $3.8M | 2024-08-09 |
| Adjuvant Global Health Technology Fund, L.P. | 10% owner | $2.5M | $4.0M | 2024-01-16 |
| Aziz Kabeer | Director | $2.5M | $4.0M | 2024-01-16 |
| Leonard Braden Michael | 10% owner | $1.6M | $3.1M | 2025-05-30 |
| Readnour Robin Shane | Director | $2.6M | $428.4K | 2026-09-09 |
| Zakrzewski Joseph S | Director | $27.8K | $1.9M | 2024-11-27 |
| Easom Eric | CEO | $114.5K | $1.6M | 2025-06-02 |
| Krause Kevin Michael | Other C-suite | $0 | $201.3K | 2024-01-09 |
| Eizen Joshua M | Other officer | $0 | $77.8K | 2026-11-05 |
| FitzPatrick Margaret M | Director | $21.8K | $0 | 2026-09-01 |
| Chanda Sanjay | Other C-suite | $0 | $13.3K | 2026-01-06 |
| Day Lucy | CFO | $0 | $12.8K | 2026-01-06 |
| Prior Stephen David | Other C-suite | $0 | $10.1K | 2026-01-06 |
| Williams Sarah Joanne | Other officer | $0 | $3.0K | 2026-09-01 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-11-18 → 2024-12-10 | 3 | $423.1K | 54 | +12.9% (+7.9% raw) | -2.3% (-11.9% raw) | +8.1% (-4.0% raw) | closed |
| 2022-03-29 | 4 | $32.3M | 42 | +15.6% (+7.5% raw) | -30.6% (-46.0% raw) | +38.7% (+20.3% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.